**
As the prevalence of GLP-1 medications rises across the United States, fast food chains are recalibrating their offerings to accommodate a burgeoning market of health-conscious consumers. The dramatic increase in usage of these weight loss drugs, including Ozempic and Wegovy, has prompted a shift in dietary patterns, compelling the multibillion-dollar fast food industry to adapt in order to stay relevant.
The Surge of GLP-1 Medications
The pharmaceutical landscape has witnessed a remarkable transformation, with GLP-1 medications generating $31.1 billion in revenue for Novo Nordisk in 2024, a significant leap from $11.9 billion in 2022. This surge has led to approximately one in eight American adults now relying on these drugs for weight management or chronic condition treatment, as highlighted by KFF, a prominent health policy organisation. The proportion of those using GLP-1s doubled from 6 per cent in May 2024 to 12 per cent by November 2025.
Despite these medications suppressing appetite, studies indicate that users continue to frequent dining establishments. A report from Data Essential in 2025 revealed that 97 per cent of GLP-1 users dine out at least once a month, with a striking 76 per cent indulging in restaurant meals weekly. This evolving consumer behaviour is being closely monitored by fast food chains eager to retain their customer base.
Fast Food Industry’s Response
The fast food sector, valued at nearly $418 billion in the U.S. as of last year, is responding to the shifting dietary landscape with innovative offerings. According to Whitney Stuart, a dietician and diabetes educator, the industry is increasingly focusing on health-aligned items, including smaller portions and protein-rich options. This shift reflects a growing cultural emphasis on convenience and affordability, which are cornerstones of American fast food culture.
Chipotle, for instance, has introduced a protein cup priced between $3.80 and $4.55, containing 32 grams of fresh grilled chicken. CEO Scott Boatwright emphasised the appeal of such offerings for consumers, including those on GLP-1 medications or adhering to specific dietary restrictions. Similarly, Smoothie King launched a dedicated “GLP-1 Support menu” in October 2024, featuring nutrient-rich smoothies designed to assist users in their weight management goals.
Other notable contributions include Shake Shack’s “Good Fit Menu,” which showcases high-protein items such as a chicken lettuce wrap and a gluten-free double burger. Although Shake Shack did not specifically target GLP-1 users, the menu choices align with their dietary needs, illustrating a broader trend among fast food restaurants to cater to health-conscious consumers.
Navigating Economic Pressures
As the fast food industry adapts, it faces the challenge of declining consumer spending on fast food and groceries, with GLP-1 users reportedly spending an average of 5 per cent less in these categories. This shift has led analysts to describe weight loss drugs as “demand disruptors,” forcing companies to rethink their strategies amid slumping sales.
Historical parallels can be drawn to the early 2000s, when restaurants introduced low-carb options to align with the Atkins diet’s popularity. However, the current GLP-1 phenomenon appears to signal a more significant shift in dietary norms, with projections suggesting that the market could reach $150 billion by 2030 and possibly benefit over 30 million U.S. users.
Sally Lyons Wyatt, chief advisor for consumer goods and foodservice insights at Circana, underscores the urgency for retailers and manufacturers to adapt to these rapidly evolving consumer priorities.
Why it Matters
The ongoing transformation within the fast food industry in response to the rise of GLP-1 medications highlights a pivotal moment in public health and consumer behaviour. As more Americans turn to these medications for weight management, restaurants must not only reconsider their menus but also their marketing strategies to attract a health-conscious clientele. This evolution reflects broader societal shifts towards prioritising health and wellness, which could have lasting implications for food consumption patterns and public health initiatives in the years to come.
